Pain News and Research

Latest Pain News and Research

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Vertebral augmentation for spinal fractures improves patient survival, reduces overall costs

Vertebral augmentation for spinal fractures improves patient survival, reduces overall costs

Prevalence of depression is twice high among migraineurs

Prevalence of depression is twice high among migraineurs

New recovery program for abdominal surgery patients improves recovery process

New recovery program for abdominal surgery patients improves recovery process

Good news: Knowing risk early, women can take action to prevent osteoporosis

Good news: Knowing risk early, women can take action to prevent osteoporosis

NIH funding helps develop chronic-pain network to accelerate research, treatments

NIH funding helps develop chronic-pain network to accelerate research, treatments

Detecting dangerous blood clots in the form of simple urine test

Detecting dangerous blood clots in the form of simple urine test

Liverpool Care Pathway provides little clinical benefit for dying cancer patients

Liverpool Care Pathway provides little clinical benefit for dying cancer patients

State highlights: Calif. Gov. Vetoes 'biosimilars' bill; health data gateway opens in Calif.; L.A. health workers required to get flu shots

State highlights: Calif. Gov. Vetoes 'biosimilars' bill; health data gateway opens in Calif.; L.A. health workers required to get flu shots

Study explores advantages of minimally invasive parathyroidectomy for treating hyperparathyroidism

Study explores advantages of minimally invasive parathyroidectomy for treating hyperparathyroidism

Study shows that brains process pain of villains more than pain of people we like

Study shows that brains process pain of villains more than pain of people we like

UTHealth researchers study how probiotic may help reduce gut inflammation in infants with colic

UTHealth researchers study how probiotic may help reduce gut inflammation in infants with colic

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Researchers develop simple blood test to identify patient with Irritable Bowel Syndrome

Researchers develop simple blood test to identify patient with Irritable Bowel Syndrome

SAGE Therapeutics obtains $20M Series B financing from two investors

SAGE Therapeutics obtains $20M Series B financing from two investors

First Edition: October 16, 2013

First Edition: October 16, 2013

Non-Hispanic black, Hispanic patients less likely to experience metabolic syndrome remission

Non-Hispanic black, Hispanic patients less likely to experience metabolic syndrome remission

ESTEVE reports positive top line results from E-58425 phase II trial for acute pain

ESTEVE reports positive top line results from E-58425 phase II trial for acute pain

Viewpoints: 'False hysteria' over health law's part-time criteria; marketplaces 'flunk' initial test; Ben Carson's surprising assessment

Viewpoints: 'False hysteria' over health law's part-time criteria; marketplaces 'flunk' initial test; Ben Carson's surprising assessment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.